Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, February 18, 2021
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
Andrew Tsai Initiated (VTGN) at Strong Buy and Held Target at $180 on, Feb 18th, 2021
Andrew Tsai of Jefferies, Initiated "Vistagen Therapeutics, Inc." (VTGN) at Strong Buy and Held Target at $180 on, Feb 18th, 2021.
Andrew has made no other calls on VTGN in the last 4 months.
There is 1 other peer that has a rating on VTGN. Out of the 1 peers that are also analyzing VTGN, 0 agree with Andrew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Andrew
- Tim Lugo of "William Blair" Upgraded from Hold to Buy on, Monday, January 4th, 2021
